Stephen Anderson
2008
In 2008, Stephen Anderson earned a total compensation of $267.1K as Former Chief Financial Officer at OncoGenex Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $70,169 |
|---|---|
| Option Awards | $136,272 |
| Salary | $60,612 |
| Total | $267,053 |
Anderson received $136.3K in option awards, accounting for 51% of the total pay in 2008.
Anderson also received $70.2K in non-equity incentive plan and $60.6K in salary.
Rankings
In 2008, Stephen Anderson's compensation ranked 8,127th out of 9,135 executives tracked by ExecPay. In other words, Anderson earned more than 11.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,127 out of 9,135 | 11th |
Division Manufacturing | 3,088 out of 3,436 | 10th |
Major group Chemicals And Allied Products | 731 out of 815 | 10th |
Industry group Drugs | 533 out of 597 | 11th |
Industry In Vitro and In Vivo Diagnostic Substances | 41 out of 51 | 20th |
Source: SEC filing on April 21, 2011.
Anderson's colleagues
We found four more compensation records of executives who worked with Stephen Anderson at OncoGenex Pharmaceuticals in 2008.